The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect ; volume:20 ; number:1 ; day:24 ; month:11 ; year:2021 ; pages:1-5 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (24.11.2021), 1-5, 12.2021
- Creator
-
Fisman, Enrique Z.
Tenenbaum, Alexander
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01412-5
- URN
-
urn:nbn:de:101:1-2022013120343664668780
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fisman, Enrique Z.
- Tenenbaum, Alexander
- SpringerLink (Online service)
Other Objects (12)
Einfluss von GIP (Gastric Inhibitory Polypeptide) und GLP-1 (Glucagon-like Peptide 7-36 Amide) auf die Insulinsekretion beim Hund
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Interaktion der GLP-1- und GIP-Rezeptoren
Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
Einfluss von GIP (Gastric Inhibitory Polypeptide) und GLP-1 (Glucagon-like Peptide 7-36 Amide) auf die Insulinsekretion beim Hund
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Interaktion der GLP-1- und GIP-Rezeptoren
Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
Einfluss von GIP (Gastric Inhibitory Polypeptide) und GLP-1 (Glucagon-like Peptide 7-36 Amide) auf die Insulinsekretion beim Hund
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Interaktion der GLP-1- und GIP-Rezeptoren